Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director James Beer sold 450 shares of Docusign stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $55.04, for a total value of $24,768.00. Following the sale, the director directly owned 15,036 shares of the company’s stock, valued at approximately $827,581.44. This trade represents a 2.91% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Docusign Stock Down 2.8%
Shares of NASDAQ DOCU opened at $50.94 on Friday. The business has a fifty day simple moving average of $47.74 and a two-hundred day simple moving average of $54.21. The firm has a market cap of $9.90 billion, a PE ratio of 34.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.92. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67.
Docusign (NASDAQ:DOCU – Get Free Report) last issued its earnings results on Thursday, June 4th. The company reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $830.24 million during the quarter, compared to analyst estimates of $824.71 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.Docusign’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.90 EPS. On average, research analysts expect that Docusign Inc. will post 1.76 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Central Pacific Bank Trust Division purchased a new position in Docusign during the 4th quarter worth $25,000. Modus Advisors LLC purchased a new position in Docusign during the 4th quarter worth $27,000. Torren Management LLC purchased a new position in Docusign during the 4th quarter worth $28,000. True Wealth Design LLC grew its stake in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after buying an additional 222 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in Docusign during the 4th quarter worth $30,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
Trending Headlines about Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: DocuSign delivered a first-quarter earnings beat, reporting $1.09 per share versus the $1.00 consensus estimate, while revenue of $830.2 million also topped expectations. The company said results were helped by stronger adoption of its AI-powered Intelligent Agreement Management platform. DocuSign (DOCU) Q1 Earnings and Revenues Beat Estimates
- Positive Sentiment: The company nudged its full-year revenue outlook higher, and one report said management raised the target by $6 million as demand for the AI-native platform improved. That suggests the business is still seeing healthy traction in its core product set. DocuSign Nudges Revenue Outlook Higher After First-Quarter Profit Rises
- Neutral Sentiment: DocuSign’s fiscal Q2 revenue guidance of $865 million-$869 million was roughly in line with the Street’s expectation, and full-year revenue guidance also appeared broadly aligned with consensus. The lack of a more aggressive outlook may be limiting the stock’s upside reaction. Docusign Announces First Quarter Fiscal 2027 Financial Results
- Neutral Sentiment: Several directors disclosed small share sales, but these transactions were made under pre-arranged 10b5-1 plans and do not appear to signal a major change in fundamentals. SEC filing: Anna Marrs Form 4
Analysts Set New Price Targets
Several research firms have recently commented on DOCU. BTIG Research reissued a “buy” rating and issued a $70.00 price target on shares of Docusign in a research report on Wednesday, March 18th. Bank of America began coverage on Docusign in a research report on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price target for the company. Weiss Ratings raised Docusign from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. JPMorgan Chase & Co. reduced their price target on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Finally, Morgan Stanley reduced their price target on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $61.40.
Get Our Latest Report on Docusign
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
